Clinical Trial Update: Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)

View source ↗

Summary

A completed clinical trial update examining fracture risk and bone mineral density in HIV-infected individuals who recently started antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Osteoporosis

Drugs mentioned

• antiretroviral therapy (ART) (antiretroviral therapy)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HIV, Osteoporosis | Status: COMPLETED